The UCSF Center for AIDS Research (CFAR) is one of 12 centers nationwide selected for a major new grant from the National Institutes of Health (NIH). All CFARs selected for the awards are based at leading AIDS research institutions around the country. The UCSF Center, headquartered at San Francisco General Hospital, will receive $5.76 million over the next four years.
The award will support ongoing UCSF work in the basic, clinical, and behavioral science areas of HIV/AIDS, with an emphasis on developing new treatment approaches, understanding the biology of HIV transmission to prevent infection, and improving the effectiveness of therapies.
Co-directors of the UCSF CFAR are Paul A. Volberding, MD, director of the UCSF AIDS Program at SFGH, and Warner C. Greene, MD, PhD, director of the UCSF-affiliated Gladstone Institute of Virology and Immunology.
"UCSF continues to be a leader in HIV research, and we are particularly pleased that this grant will support work that crosses conventional scientific boundaries," Volberding said. "In this way, we can rapidly apply insights from basic laboratory research to address our patients' problems. The CFAR grant allows us to become an even more effective research community."
First funded through NIH in 1988, the CFAR program is designed to provide a national pool of shared resources that is made available to AIDS researchers at the local level. Through this network several major advances in AIDS research have evolved, including identification of new co-receptors for HIV, the role of cytotoxic T-lymphocytes in early infection and in controlling virus replication, and the use of anti-retroviral drugs as probes to understand the dynamics of HIV replication.
The overall mission of the CFAR program is to support AIDS research by
facilitating interdisciplinary and international interactions, technology
transfer through academic-industry collaborations, research dissemination
activities, and community outreac
Contact: Corinna Kaarlela
University of California - San Francisco